Catherine A Cotter

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

High Fat Diet Induced

Respiratory Tract

Immune Response

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine Jacob-Dolan, Darren M Ty, David L Hope, Katherine A McMahan, Jinyan Liu, Olivia C Powers, Catherine A Cotter, Michela Sciacca, Cindy Wu, Erica Borducchi, Emily Bouffard, Hannah Richter, Jason Velasco, Elyse Teow, Mona Boursiquot, Anthony Cook, Karen Feliciano, Jake Yalley-Ogunro, Michael S Seaman, Laurent Pessiant, Mark G Lewis, Hanne A Elyard, Bernard Moss, Dan H Barouch
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Science translational medicine 16 (740) (2024)
Catherine Jacob-Dolan, Darren M Ty, David L Hope, Katherine A McMahan, Jinyan Liu, Olivia C Powers, Catherine A Cotter, Michela Sciacca, Cindy Wu, Erica Borducchi, Emily Bouffard, Hannah Richter, Jason Velasco, Elyse Teow, Mona Boursiquot, Anthony Cook, Karen Feliciano, Jake Yalley-Ogunro, Michael S Seaman, Laurent Pessiant, Mark G Lewis, Hanne A Elyard, Bernard Moss, Dan H Barouch
Comparison of the immunogenicity and protective efficacy of ACAM2000, MVA, and vectored subunit vaccines for Mpox in rhesus macaques. Science translational medicine 16 (740) (2024)
Catherine A Cotter, Jeffrey L Americo, Patricia L Earl, Bernard Moss
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice. NPJ vaccines 8 (1) (2023)
Catherine A Cotter, Jeffrey L Americo, Patricia L Earl, Bernard Moss
Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice. NPJ vaccines 8 (1) (2023)
Jeffrey L Americo, Catherine A Cotter, Patricia L Earl, Ruikang Liu, Bernard Moss
Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection. Proceedings of the National Academy of Sciences of the United States of America 119 (24) (2022)
Ruikang Liu, Jeffrey L Americo, Catherine A Cotter, Patricia L Earl, Noam Erez, Chen Peng, Bernard Moss
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection. Proceedings of the National Academy of Sciences of the United States of America 118 (12) (2021)